Human medicines European public assessment report EPAR Remicade infliximab Spondylitis AnkylosingArthritis RheumatoidPsoriasisCrohn DiseaseArthritis PsoriaticColitis Ulcerative Date of authorisation 13081999 Revision 52 Status Author

Human medicines European public assessment report EPAR Remicade infliximab Spondylitis AnkylosingArthritis RheumatoidPsoriasisCrohn DiseaseArthritis PsoriaticColitis Ulcerative Date of authorisation 13081999 Revision 52 Status Authorised